Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.4' has been added, replacing the previous 'Revision: v3.5.3' to reflect a minor site update.
    Difference
    0.1%
    Check dated 2026-05-17T09:13:51.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the clinical trial details shown on the page.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:24.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:30:34.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:13:44.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:56.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:20:48.000Z thumbnail image

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.